Literature DB >> 31691290

Laparoscopic resection for Bismuth type III and IV hilar cholangiocarcinoma: How to improve the radicality without direct palpation.

Feng Feng1, Xuehui Cao1, Xueqing Liu1, Jianzhang Qin1, Shubin Zhang1, Qiusheng Li1, Jianhua Liu1.   

Abstract

BACKGROUND: Open surgery for hilar cholangiocarcinoma (HCCA) has already been widely reported and analyzed. However, the laparoscopic technique for treating HCCA remains controversial because of the lack of radicality and poor assessment of the resectability of hilar structures without direct palpation. The aim of this study was to provide detailed surgical procedures and photographs of this technically demanding operation, describe our experience in assessing resectability before and during surgery, and confirm the radicality of laparoscopic resection of Bismuth type III and IV HCCA.
METHODS: From November 2016 to November 2018, nine patients received laparoscopic resection of Bismuth type III or IV HCCA in our department.
RESULTS: Laparoscopic right hepatectomy was performed in four patients, and laparoscopic left hepatectomy was performed in five patients. Negative margins were achieved in all patients. Complications were found in two (22.22%) patients, with bile leakage and hepatic insufficiency each in one patient. The patient developing hepatic insufficiency had persistent and ongoing liver failure and finally expired.
CONCLUSION: The radicality of laparoscopic resection for Bismuth type III and IV HCCA can be technically improved through extended lymphadenectomy, visual assessment of hilar structures, and frozen section techniques.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  hilar cholangiocarcinoma; laparoscopic; radicality

Mesh:

Year:  2019        PMID: 31691290     DOI: 10.1002/jso.25739

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Laparoscopic versus open surgery for hilar cholangiocarcinoma: a retrospective cohort study on short-term and long-term outcomes.

Authors:  Delin Ma; Wei Wang; Jianlei Wang; Tingxiao Zhang; Zhaochen Jiang; Gang Du; Jinhuan Yang; Xiqing Zhang; Guanjun Qin; Bin Jin
Journal:  Surg Endosc       Date:  2021-08-16       Impact factor: 3.453

2.  The Long-Term Outcome of Laparoscopic Resection for Perihilar Cholangiocarcinoma Compared with the Open Approach: A Real-World Multicentric Analysis.

Authors:  Tingting Qin; Min Wang; Hang Zhang; Jingdong Li; Xiaxing Deng; Yuhua Zhang; Wenxing Zhao; Ying Fan; Dewei Li; Xuemin Chen; Yechen Feng; Siwei Zhu; Zhongqiang Xing; Guangsheng Yu; Jian Xu; Junjie Xie; Changwei Dou; Hongqin Ma; Gangshan Liu; Yue Shao; Weibo Chen; Simiao Xu; Jun Liu; Jianhua Liu; Xinmin Yin; Renyi Qin
Journal:  Ann Surg Oncol       Date:  2022-10-22       Impact factor: 4.339

Review 3.  Systematic review of perioperative and oncologic outcomes of minimally-invasive surgery for hilar cholangiocarcinoma.

Authors:  Federica Cipriani; Francesca Ratti; Guido Fiorentini; Raffaella Reineke; Luca Aldrighetti
Journal:  Updates Surg       Date:  2021-02-22

Review 4.  Minimally invasive liver surgery: the Charité experience.

Authors:  Maximilian Nösser; Linda Feldbrügge; Johann Pratschke
Journal:  Turk J Surg       Date:  2021-09-28

Review 5.  Laparoscopic liver resection: indications, limitations, and economic aspects.

Authors:  Moritz Schmelzle; Felix Krenzien; Wenzel Schöning; Johann Pratschke
Journal:  Langenbecks Arch Surg       Date:  2020-07-01       Impact factor: 3.445

6.  Complete laparoscopic radical resection of hilar cholangiocarcinoma: technical aspects and long-term results from a single center.

Authors:  Jingdong Li; Yongfu Xiong; Gang Yang; Lixing Zhang; Muhammad Riaz; Jian Xu; Qiang Li; Zhaohui Tang
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-07-16       Impact factor: 1.195

7.  Minimally invasive versus open radical resection surgery for hilar cholangiocarcinoma: Comparable outcomes associated with advantages of minimal invasiveness.

Authors:  Wei Tang; Jian-Guo Qiu; Xin Deng; Shan-Shan Liu; Luo Cheng; Jia-Rui Liu; Cheng-You Du
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.